Tau has emerged as a sensitive marker for Alzheimer’s disease [27] and NfL is a sensitive marker for axonal injury extensively studied in multiple sclerosis and traumatic brain injury [20, 28–30]. This evidence concerns the gene MAPT and multiple sclerosis.